| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| Aditya Birla SL Nifty Healthcare ETF (G) |
| [Equity: Sectoral] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
-0.04 |
| Equity |
100.00 |
| Trep |
0.04 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
49.81% |
| Top 10 Holdings |
76.17% |
| Top 25 Holdings |
100.00% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
79.04 |
| Healthcare |
20.96 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
4.68 |
| PE Ratio |
35.26 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Sun Pharmaceutical Industries Limited |
18.05 |
| DIVI LABORATORIES LTD. |
8.21 |
| Cipla Limited |
7.96 |
| Dr Reddys Laboratories Limited |
7.93 |
| Apollo Hospitals Enterprise Limited |
7.66 |
| Max Healthcare Institute Limited |
7.60 |
| Lupin Limited |
5.58 |
| Fortis Health Care Ltd |
4.74 |
| Torrent Pharmaceuticals Limited |
4.43 |
| Laurus Labs Limited |
4.01 |
| Aurobindo Pharma Limited |
3.61 |
| Alkem Laboratories Limited |
3.55 |
| Glenmark Pharmaceuticals Limited |
3.24 |
| Biocon Limited |
2.80 |
| Mankind Pharma Limited |
2.57 |
| Zydus Lifesciences Limited |
2.37 |
| IPCA Laboratories Limited |
2.18 |
| Abbott India Limited |
1.53 |
| Piramal Pharma Limited |
1.02 |
| Syngene International Limited |
0.96 |
| Clearing Corporation of India Limited |
0.04 |
| Net Current Assets |
-0.01 |
| Net Receivables / (Payables) |
-0.03 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|